Medicare Enrolled
Dr. Amin Farah, MD
Cardiovascular Disease · Lynwood, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Farah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Farah
Dr. Amin Farah is a cardiovascular disease specialist in Lynwood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Farah performed 2,853 Medicare services across 1,713 unique beneficiaries.
Between the years covered by Open Payments, Dr. Farah received a total of $5,562 from 29 pharmaceutical and/or device companies across 318 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Farah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 37% volume in CA
$5,562 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,853
Medicare services
Top 37% in CA for cardiovascular disease
1,713
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~150 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
561 | $12 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
523 | $103 | $205 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
392 | $68 | $157 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
147 | $168 | $650 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
139 | $60 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
125 | $78 | $140 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
120 | $7 | $20 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
96 | $47 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
88 | $102 | $224 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
81 | $149 | $497 |
| Annual depression screening | 81 | $21 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
77 | $144 | $245 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
49 | $76 | $269 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 47 | $20 | $30 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
47 | $219 | $440 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
47 | $34 | $40 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
35 | $156 | $445 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
25 | $200 | $700 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
25 | $112 | $370 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
25 | $1 | $20 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
24 | $56 | $300 |
| New patient office visit, complex (60-74 min) | 24 | $169 | $390 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
22 | $415 | $950 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
19 | $70 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $111 | $390 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $118 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.7% high complexity
11.3% medium
82.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,562
Total received (2018-2024)
Avg $795/year across 7 years
Top 38% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
318
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,562 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,110
2023
$974
2022
$744
2021
$1,033
2020
$732
2019
$407
2018
$563
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$186
Novartis Pharmaceuticals Corporation
$185
SCPHARMACEUTICALS INC.
$129
Kiniksa Pharmaceuticals International, plc
$114
Janssen Pharmaceuticals, Inc
$94
Edwards Lifesciences Corporation
$86
AstraZeneca Pharmaceuticals LP
$85
E.R. Squibb & Sons, L.L.C.
$46
ABIOMED
$46
Merck Sharp & Dohme LLC
$45
Lexicon Pharmaceuticals, Inc.
$38
PFIZER INC.
$35
Bayer Healthcare Pharmaceuticals Inc.
$22
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,146
Janssen Pharmaceuticals, Inc
$799
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$737
Amarin Pharma Inc.
$380
Merck Sharp & Dohme LLC
$282
SANOFI-AVENTIS U.S. LLC
$235
PFIZER INC.
$231
E.R. Squibb & Sons, L.L.C.
$202
AstraZeneca Pharmaceuticals LP
$189
Amgen Inc.
$170
SCPHARMACEUTICALS INC.
$154
Edwards Lifesciences Corporation
$141
Regeneron Healthcare Solutions, Inc.
$121
Kiniksa Pharmaceuticals International, plc
$114
Boston Scientific Corporation
$99
ABIOMED
$97
Merck Sharp & Dohme Corporation
$81
Medtronic, Inc.
$66
Lexicon Pharmaceuticals, Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Abbott Laboratories
$39
Medtronic Vascular, Inc.
$34
Esperion Therapeutics, Inc.
$25
CVRx, Inc.
$25
Kestra Medical Technology Services, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Preventice Services, LLC
$21
BOSTON SCIENTIFIC CORPORATION
$15
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 48.2% of all-time payments
Associated products mentioned in payments ›
Arcalyst · Assure WCD · BG Mini Plus · BRILINTA · Barostim Neo System · CAMZYOS · CareLink · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · FARXIGA · FUROSCIX · Impella · Inpefa · JARDIANCE · Kerendia · LATITUDE · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · NEXLETOL · PRALUENT · Pacemakers · Repatha · Reveal LINQ · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
650
Per 100K population
6.6
County median income
$87,760
Nearest hospital
SAINT FRANCIS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Farah is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Farah experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Farah performed 561 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farah receive payments from pharmaceutical companies?
Yes. Dr. Farah received a total of $5,562 from 29 companies across 318 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farah's costs compare to other cardiologists in Lynwood?
Dr. Farah's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Lynwood
Browse cardiologists in Lynwood ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology